ZNG1F
gene geneOn this page
Also known as OTTHUMG00000066820OTTHUMG00000067194
Summary
ZNG1F (Zn regulated GTPase metalloprotein activator 1F, HGNC:31978) is a protein-coding gene on chromosome 9p11.2, encoding Zinc-regulated GTPase metalloprotein activator 1F (Q4V339). Zinc chaperone that directly transfers zinc cofactor to target metalloproteins, thereby activating them.
Predicted to enable GTP binding activity; hydrolase activity; and metal ion binding activity. Predicted to be located in nucleus. Predicted to be active in cytoplasm.
Source: NCBI Gene 644019 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 41 total
- MANE Select transcript:
NM_001085457
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31978 |
| Approved symbol | ZNG1F |
| Name | Zn regulated GTPase metalloprotein activator 1F |
| Location | 9p11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OTTHUMG00000066820, OTTHUMG00000067194 |
| Ensembl gene | ENSG00000215126 |
| Ensembl biotype | protein_coding |
| Entrez | 644019 |
Gene structure
Transcript identifiers
Ensembl transcripts: 27 — 12 protein_coding, 6 nonsense_mediated_decay, 6 protein_coding_CDS_not_defined, 3 retained_intron
ENST00000377391, ENST00000382436, ENST00000456520, ENST00000457288, ENST00000467791, ENST00000486387, ENST00000490294, ENST00000494538, ENST00000610358, ENST00000610377, ENST00000611553, ENST00000613125, ENST00000613716, ENST00000617722, ENST00000617917, ENST00000620776, ENST00000622791, ENST00000894097, ENST00000894098, ENST00000894099, ENST00000894100, ENST00000894101, ENST00000894102, ENST00000894103, ENST00000894104, ENST00000894105, ENST00000958079
RefSeq mRNA: 3 — MANE Select: NM_001085457
NM_001085457, NM_001386876, NM_001386877
CCDS: CCDS43827
Canonical transcript exons
ENST00000377391 — 15 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001604394 | 41131309 | 41131840 |
| ENSE00001885224 | 41189105 | 41189317 |
| ENSE00004012905 | 41183564 | 41183660 |
| ENSE00004012906 | 41162333 | 41162377 |
| ENSE00004012907 | 41185993 | 41186079 |
| ENSE00004012908 | 41145281 | 41145332 |
| ENSE00004012909 | 41182375 | 41182466 |
| ENSE00004012910 | 41174293 | 41174352 |
| ENSE00004012911 | 41133674 | 41133742 |
| ENSE00004012912 | 41132228 | 41132357 |
| ENSE00004012913 | 41166784 | 41166830 |
| ENSE00004012914 | 41172712 | 41172749 |
| ENSE00004012915 | 41133505 | 41133570 |
| ENSE00004012916 | 41156383 | 41156439 |
| ENSE00004012917 | 41165001 | 41165087 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 91.60.
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cerebellar cortex | UBERON:0002129 | 91.60 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 91.60 | gold quality |
| cerebellum | UBERON:0002037 | 91.38 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 90.93 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 90.93 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 88.92 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 88.91 | gold quality |
| primary visual cortex | UBERON:0002436 | 88.79 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 88.03 | gold quality |
| granulocyte | CL:0000094 | 87.72 | gold quality |
| right uterine tube | UBERON:0001302 | 87.49 | gold quality |
| right frontal lobe | UBERON:0002810 | 87.17 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 87.13 | gold quality |
| nucleus accumbens | UBERON:0001882 | 87.01 | gold quality |
| adenohypophysis | UBERON:0002196 | 86.97 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 86.56 | gold quality |
| pituitary gland | UBERON:0000007 | 86.55 | gold quality |
| skin of abdomen | UBERON:0001416 | 86.40 | gold quality |
| skin of leg | UBERON:0001511 | 86.32 | gold quality |
| body of pancreas | UBERON:0001150 | 86.29 | gold quality |
| zone of skin | UBERON:0000014 | 86.28 | gold quality |
| Ammon’s horn | UBERON:0001954 | 86.26 | gold quality |
| caudate nucleus | UBERON:0001873 | 86.12 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 85.95 | gold quality |
| putamen | UBERON:0001874 | 85.90 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 85.86 | gold quality |
| brain | UBERON:0000955 | 85.68 | gold quality |
| cortex of kidney | UBERON:0001225 | 85.14 | gold quality |
| spleen | UBERON:0002106 | 85.03 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 84.95 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 19.19 |
| E-MTAB-6524 | no | 17.84 |
| E-HCAD-31 | no | 2.03 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
51 targeting ZNG1F, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-568 | 99.98 | 69.86 | 2084 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
| HSA-MIR-548AU-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AY-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548B-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548BB-5P | 99.94 | 71.27 | 3509 |
| HSA-MIR-548C-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548D-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548H-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548I | 99.94 | 71.25 | 3481 |
| HSA-MIR-548J-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548O-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548W | 99.94 | 71.24 | 3488 |
| HSA-MIR-548Y | 99.94 | 71.28 | 3514 |
| HSA-MIR-101-3P | 99.94 | 75.03 | 2230 |
| HSA-MIR-380-3P | 99.89 | 70.18 | 1978 |
| HSA-MIR-221-3P | 99.86 | 71.56 | 1329 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | cbwd | ENSDARG00000004318 |
| mus_musculus | Zng1 | ENSMUSG00000024878 |
| rattus_norvegicus | Zng1a | ENSRNOG00000015516 |
Paralogs (4): ZNG1B (ENSG00000136682), ZNG1E (ENSG00000147996), ZNG1A (ENSG00000172785), ZNG1C (ENSG00000196873)
Protein
Protein identifiers
Zinc-regulated GTPase metalloprotein activator 1F — Q4V339 (reviewed: Q4V339)
Alternative names: Cobalamin synthase W domain-containing protein 6
All UniProt accessions (8): A0A087WU66, A0A087WX94, A0A087X1C0, A0A0B4J2E3, Q4V339, F2Z3P0, H0Y5V3, Q5JTY2
UniProt curated annotations — full annotation on UniProt →
Function. Zinc chaperone that directly transfers zinc cofactor to target metalloproteins, thereby activating them. Catalyzes zinc insertion into the active site of methionine aminopeptidase METAP1, which function to cleave the initiator methionine from polypeptides during or after protein translation. Mechanistically, the N-terminal psi-PxLVp motif binds to the C6H2-type zinc finger of inactive form of METAP1. After formation of the docked complex, zinc is transferred from the CXCC motif in the GTPase domain of ZNG1F to the zinc binding site in the peptidase domain of METAP1 in a process requiring GTP hydrolysis. GTP/GDP exchange is required for release of active METAP1.
Subcellular location. Nucleus.
Similarity. Belongs to the SIMIBI class G3E GTPase family. ZNG1 subfamily.
RefSeq proteins (3): NP_001078926, NP_001373805, NP_001373806 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003495 | CobW/HypB/UreG_nucleotide-bd | Domain |
| IPR011629 | CobW-like_C | Domain |
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
| IPR036627 | CobW-likC_sf | Homologous_superfamily |
| IPR051316 | Zinc-reg_GTPase_activator | Family |
Pfam: PF02492, PF07683
Catalyzed reactions (Rhea), 1 shown:
- GTP + H2O = GDP + phosphate + H(+) (RHEA:19669)
UniProt features (12 total): binding site 6, short sequence motif 2, chain 1, domain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q4V339-F1 | 75.86 | 0.35 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (6): 110; 203–206; 49–56; 107; 109; 110–114
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 34 (showing top):
chr9p11, GOBP_PROTEIN_MATURATION, GOMF_METALLOCHAPERONE_ACTIVITY, GOMF_MOLECULAR_CARRIER_ACTIVITY, NFE2L2.V2, MIR559, MIR548Y, MIR548BB_5P, MIR548AR_5P, MIR548AD_5P_MIR548AE_5P_MIR548AY_5P_MIR548B_5P_MIR548D_5P, MIR548AK_MIR548AM_5P_MIR548C_5P_MIR548H_5P_MIR548O_5P_MIR548AU_5P, MIR548O_5P_MIR548W, MIR548AB, MIR548AS_5P, MIR548A_5P
GO Biological Process (0):
GO Molecular Function (4): GTP binding (GO:0005525), hydrolase activity (GO:0016787), metal ion binding (GO:0046872), nucleotide binding (GO:0000166)
GO Cellular Component (2): nucleus (GO:0005634), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| guanyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| catalytic activity | 1 |
| cation binding | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
286 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNG1F | SETD2 | Q9BYW2 | 549 |
| ZNG1F | ANKRD20A3P | Q5VUR7 | 544 |
| ZNG1F | FAM72C | H0Y354 | 491 |
| ZNG1F | FAM72B | Q86X60 | 484 |
| ZNG1F | ANKRD20A2P | Q5SQ80 | 479 |
| ZNG1F | ANKRD20A4P | Q4UJ75 | 477 |
| ZNG1F | HSPB3 | Q12988 | 469 |
| ZNG1F | FAM72D | Q6L9T8 | 449 |
| ZNG1F | ANKRD20A1 | Q5TYW2 | 435 |
| ZNG1F | ZNF836 | Q6ZNA1 | 430 |
| ZNG1F | FAM72A | Q5TYM5 | 427 |
| ZNG1F | ABRA | Q8N0Z2 | 413 |
| ZNG1F | DHRS4L2 | Q6PKH6 | 400 |
| ZNG1F | B8ZZ87 | B8ZZ87 | 379 |
| ZNG1F | TBC1D19 | Q8N5T2 | 370 |
IntAct
18 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RNASEH2C | RNASEH2A | psi-mi:“MI:0914”(association) | 0.640 |
| KLK5 | DENND11 | psi-mi:“MI:0914”(association) | 0.640 |
| ILVBL | SLC33A1 | psi-mi:“MI:0914”(association) | 0.530 |
| ECE1 | ZNG1F | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNG1B | TCERG1 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNG1A | AGAP1 | psi-mi:“MI:0914”(association) | 0.350 |
| HDAC7 | ZMYM6 | psi-mi:“MI:0914”(association) | 0.350 |
| ELK1 | TPP1 | psi-mi:“MI:0914”(association) | 0.350 |
| ELK1 | PPP6C | psi-mi:“MI:0914”(association) | 0.350 |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| MRPL27 | psi-mi:“MI:0914”(association) | 0.350 | |
| ZNG1B | NME4 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNG1A | TCERG1 | psi-mi:“MI:0914”(association) | 0.350 |
| FAM170A | RPSA2 | psi-mi:“MI:0914”(association) | 0.350 |
| DTWD2 | ATP1A3 | psi-mi:“MI:0914”(association) | 0.350 |
| P/V | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (11): CBWD6 (Affinity Capture-MS), CBWD6 (Affinity Capture-MS), CBWD6 (Affinity Capture-MS), CBWD6 (Affinity Capture-MS), CBWD6 (Reconstituted Complex), CBWD6 (Affinity Capture-MS), CBWD6 (Affinity Capture-MS), CBWD6 (Affinity Capture-MS), CBWD6 (Affinity Capture-MS), CBWD6 (Affinity Capture-MS), CBWD6 (Affinity Capture-MS)
ESM2 similar proteins: A0A078BQP2, A0A131MCZ8, A0JN54, A3KGB4, A3QM97, A8WPG9, G5ED05, O16715, O88673, P11528, P20192, P23743, P23897, P25092, P30733, P33530, P49619, P49620, P49621, P51556, P55141, P55204, P70106, P90895, P91550, Q03603, Q09435, Q0IIM8, Q10029, Q17586, Q19954, Q22949, Q23681, Q3UWA6, Q4V339, Q4V3C7, Q5JTY5, Q5RIA9, Q618H8, Q67XQ0
Diamond homologs: B0R0B1, O74310, P24203, P31521, P33030, P53729, P94400, Q4V339, Q5JTY5, Q5RIA9, Q8IUF1, Q8VEH6, Q99MB4, Q9BRT8, P22042, P29937, Q869Q0, Q9HZQ2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
41 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 32 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1398 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:41131837:CTGC:C | acceptor_gain | 1.0000 |
| 9:41131841:C:CC | acceptor_gain | 1.0000 |
| 9:41132221:GACTT:G | donor_loss | 1.0000 |
| 9:41132222:ACTT:A | donor_loss | 1.0000 |
| 9:41132223:CTT:C | donor_loss | 1.0000 |
| 9:41132224:TTA:T | donor_loss | 1.0000 |
| 9:41132225:TA:T | donor_loss | 1.0000 |
| 9:41132226:A:AC | donor_gain | 1.0000 |
| 9:41132226:A:C | donor_loss | 1.0000 |
| 9:41132226:AC:A | donor_gain | 1.0000 |
| 9:41132227:C:CT | donor_gain | 1.0000 |
| 9:41132227:CC:C | donor_gain | 1.0000 |
| 9:41132227:CCA:C | donor_gain | 1.0000 |
| 9:41132227:CCAA:C | donor_gain | 1.0000 |
| 9:41132227:CCAAT:C | donor_gain | 1.0000 |
| 9:41133699:T:TA | donor_gain | 1.0000 |
| 9:41133739:TACT:T | acceptor_gain | 1.0000 |
| 9:41133740:ACTCT:A | acceptor_loss | 1.0000 |
| 9:41133741:CT:C | acceptor_gain | 1.0000 |
| 9:41133743:C:A | acceptor_loss | 1.0000 |
| 9:41133743:C:CC | acceptor_gain | 1.0000 |
| 9:41133744:T:G | acceptor_loss | 1.0000 |
| 9:41133751:C:CT | acceptor_gain | 1.0000 |
| 9:41133752:A:T | acceptor_gain | 1.0000 |
| 9:41164983:A:C | donor_gain | 1.0000 |
| 9:41182369:TCTTA:T | donor_loss | 1.0000 |
| 9:41182370:CTTA:C | donor_loss | 1.0000 |
| 9:41182371:TTACC:T | donor_loss | 1.0000 |
| 9:41182372:TACCA:T | donor_loss | 1.0000 |
| 9:41182373:A:AG | donor_loss | 1.0000 |
AlphaMissense
2598 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:41165052:T:A | K204I | 0.982 |
| 9:41133566:A:G | L297P | 0.978 |
| 9:41131831:A:G | L364S | 0.973 |
| 9:41132233:A:G | L359P | 0.972 |
| 9:41132317:A:T | V331D | 0.969 |
| 9:41131840:C:T | G361D | 0.968 |
| 9:41132236:A:T | V358D | 0.967 |
| 9:41133505:C:A | K317N | 0.965 |
| 9:41133505:C:G | K317N | 0.965 |
| 9:41156403:A:C | F248L | 0.964 |
| 9:41156403:A:T | F248L | 0.964 |
| 9:41156405:A:G | F248L | 0.964 |
| 9:41131816:A:G | L369P | 0.957 |
| 9:41133509:A:G | L316P | 0.957 |
| 9:41132357:C:G | G318R | 0.956 |
| 9:41132357:C:T | G318R | 0.956 |
| 9:41131840:C:A | G361V | 0.954 |
| 9:41132242:C:G | R356P | 0.954 |
| 9:41133732:G:A | T276I | 0.950 |
| 9:41165070:T:A | D198V | 0.946 |
| 9:41133680:A:C | F293L | 0.945 |
| 9:41133680:A:T | F293L | 0.945 |
| 9:41133682:A:G | F293L | 0.945 |
| 9:41132228:C:G | G361R | 0.943 |
| 9:41165051:T:A | K204N | 0.943 |
| 9:41165051:T:G | K204N | 0.943 |
| 9:41132356:C:T | G318E | 0.941 |
| 9:41133512:C:G | R315T | 0.937 |
| 9:41132244:A:C | N355K | 0.936 |
| 9:41132244:A:T | N355K | 0.936 |
dbSNP variants (sampled 300 via entrez): RS1000201935 (9:41145888 G>A), RS1000453851 (9:41184651 C>T), RS1000506989 (9:41150829 C>T), RS1000535819 (9:41150449 C>A,T), RS1000659552 (9:41169468 G>A), RS1000725796 (9:41161095 C>A), RS1000787162 (9:41190097 T>C), RS1001046831 (9:41134212 A>G,T), RS1001094430 (9:41166787 G>A), RS1001188971 (9:41162318 G>T), RS1001295075 (9:41185205 G>A), RS1001465984 (9:41132028 A>G), RS1001497142 (9:41130941 G>T), RS1001520252 (9:41133863 A>C,G), RS1001730774 (9:41147548 CTA>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| fenpyroximate | decreases expression | 1 |
| 4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide | decreases expression | 1 |
| abrine | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| Antimycin A | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.